MAPK1 and hepatocellular carcinoma: The simultaneous activation of ERK and AKT pathways enhance cell cycle progression in Hepatitis B virus (HBV)-replicating hepatocytes whereas HCV envelop protein activates the ERK pathway to facilitate human hepatoma cell proliferation and survival [18].